Reversing paclitaxel resistance in ovarian cancer cells via inhibition of the ABCB1 expressing side population.

MLA

Eyre, Rachel, et al. “Reversing Paclitaxel Resistance in Ovarian Cancer Cells via Inhibition of the ABCB1 Expressing Side Population.” Tumour Biology : The Journal of the International Society for Oncodevelopmental Biology and Medicine, vol. 35, no. 10, Oct. 2014, pp. 9879–92. EBSCOhost, https://doi.org/10.1007/s13277-014-2277-2.

APA

Eyre, R., Harvey, I., Stemke-Hale, K., Lennard, T. W. J., Tyson-Capper, A., & Meeson, A. P. (2014). Reversing paclitaxel resistance in ovarian cancer cells via inhibition of the ABCB1 expressing side population. Tumour Biology : The Journal of the International Society for Oncodevelopmental Biology and Medicine, 35(10), 9879–9892. https://doi.org/10.1007/s13277-014-2277-2

Chicago

Eyre, Rachel, Ian Harvey, Katherine Stemke-Hale, Thomas W J Lennard, Alison Tyson-Capper, and Annette P Meeson. 2014. “Reversing Paclitaxel Resistance in Ovarian Cancer Cells via Inhibition of the ABCB1 Expressing Side Population.” Tumour Biology : The Journal of the International Society for Oncodevelopmental Biology and Medicine 35 (10): 9879–92. doi:10.1007/s13277-014-2277-2.